Arlington Partners’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Arlington Partners's AMGN Position: Q3 2023 in Review
Arlington Partners sold out of Amgen (AMGN) in Q3 2023, closing a stake of 3,631 shares — an estimated $806K sold.
Arlington Partners first reported a position in AMGN in Q1 2018 and held it in 21 quarters. The position peaked at $899K in Q1 2023. 2,501 funds tracked by Wall St. Rank hold AMGN as of Q3 2023.
- Arlington Partners reported no remaining Amgen position as of Q3 2023 after selling out during the quarter.
- Arlington Partners sold 3,631 Amgen shares in Q3 2023, an estimated $806K.
- Arlington Partners first reported a position in Amgen in Q1 2018 and held it in 21 quarters.
- Arlington Partners's Amgen position peaked at $899K in Q1 2023.
- 2,501 funds tracked by Wall St. Rank held Amgen as of Q3 2023.
Based on Arlington Partners's 13F filing for Q3 2023, filed 24 Oct 2023.